Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners

Annals of Pharmacotherapy

Volumn 50, Issue 6, 2016, Pages 446-454

  Luymes, Clare H ^a   van der Kleij, Rianne M J J ^a   Poortvliet, Rosalinde K E ^a   de Ruijter, Wouter ^a   Reis, Ria ^a,b,c   Numans, Mattijs E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

cardiovascular drugs; family medicine; general medicine; preventive medicine; withdrawal

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONSULTATION; DEPRESCRIPTION; DRUG WITHDRAWAL; FAMILY HISTORY; FAMILY MEDICINE; FEMALE; GENERAL PRACTITIONER; HUMAN; MALE; MIDDLE AGED; POTENTIALLY INAPPROPRIATE MEDICATION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; CARDIOVASCULAR DISEASES; CLINICAL PRACTICE; CLINICAL TRIAL; ECONOMICS; PRACTICE GUIDELINE; RISK FACTOR; STANDARDS; STATISTICS AND NUMERICAL DATA;

ADULT; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DEPRESCRIPTIONS; FEMALE; GENERAL PRACTITIONERS; HUMANS; MALE; MIDDLE AGED; POTENTIALLY INAPPROPRIATE MEDICATION LIST; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; RISK FACTORS;

EID: 84966971041     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028016637181     Document Type: Article

References (19)

1. T.WiersmaY.M.SmuldersC.D.StehouwerK.T.KoningsJ.LanphenSummary of the multidisciplinary guideline on cardiovascular risk management (revision 2011) [in Dutch]. Ned Tijdschr Geneeskd. 2012;156:A5104.
2. Cardiovascular Disease Risk Assessment Steering Group. New Zealand Primary Care Handbook 2012. Wellington, New Zealand: Ministry of Health; 2013. http://www.health.govt.nz/publication/new-zealand-primary-care-handbook-2012. Accessed February 19, 2016.
3. National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee). Guide to Management of Hypertension 2008. Canberra, Australia: Heart Foundation; 2010. http://heartfoundation.org.au/images/uploads/publications/HypertensionGuidelines2008to2010Update.pdf
4. Newcastle Guideline Development and Research Unit; Updated by the National Clinical Guideline Centre (formerly the National Collaborating Centre for Chronic Conditions) and the British Hypertension Society. Hypertension: Clinical Management of Primary Hypertension in Adults. London, UK: National Institute for Health and Clinical Excellence; 2011. http://www.ehs-egypt.net/pdf/WhatsnewNICE2011.pdf
5. H.GohlkeS.GielenW.KönigG.SchulerB.RauchF.SonntagESC Pocket Guidelines Prävention von Herz-Kreislauf-Erkrankungen. Düsseldorf, Germany: Deutsche Gesellschaft für Kardiologie—Herz und Kreislauf Forschung eV (DGK); 2012. http://leitlinien.dgk.org/files/PL_Pr%C3%A4vention_Internet_13.pdf. Accessed February 19, 2016.
6. J.PerkG.De BackerH.Gohlke. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635-1701.
7. H.J.van DuijnJ.N.BeloJ.W.BlomI.D.VelbergW.J.AssendelftRevised guidelines for cardiovascular risk management: time to stop medication? A practice-based intervention study. Br J Gen Pract. 2011;61:347-352.
8. E.ReeveJ.ToI.HendrixS.ShakibM.S.RobertsM.D.WiesePatient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30:793-807.
9. M.H.BeersJ.G.OuslanderI.RollingherD.B.ReubenJ.BrooksJ.C.BeckExplicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151:1825-1832.
10. C.CahirK.BennettC.TeljeurT.FaheyPotentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol. 2014;77:201-210.
11. K.AndersonD.StowasserC.FreemanI.ScottPrescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4:e006544.
12. M.N.MarshallSampling for qualitative research. Fam Pract. 1996;13:522-526.
13. H.F.HsiehS.E.ShannonThree approaches to qualitative content analysis. Qual Health Res. 2005;15:1277-1288.
14. M.B.MilesA.M.HubermanQualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks, CA: Sage; 1994.
15. C.MorecroftJ.CantrillM.P.TullyPatients’ evaluation of the appropriateness of their hypertension management: a qualitative study. Res Social Adm Pharm. 2006;2:186-211.
16. C.MorecroftJ.CantrillM.P.TullyIndividual patient’s preferences for hypertension management: a Q-methodological approach. Patient Educ Couns. 2006;61:354-362.
17. G.M.LeydonL.RodgersT.KendrickA qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Fam Pract. 2007;24:570-575.
18. J.BensonN.BrittenPatients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325:873.
19. M.M.NielenW.J.AssendelftA.J.DrenthenP.van den HomberghI.van DisF.G.SchellevisPrimary prevention of cardio-metabolic diseases in general practice: a Dutch survey of attitudes and working methods of general practitioners. Eur J Gen Pract. 2010;16:139-142.